| The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion N Petrović, V Mandušić, B Stanojević, S Lukić, L Todorović, J Roganović, ... Medical oncology 31, 1-9, 2014 | 56 | 2014 |
| Estrogen receptor beta: the promising biomarker and potential target in metastases A Božović, V Mandušić, L Todorović, M Krajnović International Journal of Molecular Sciences 22 (4), 1656, 2021 | 46 | 2021 |
| Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats E Sudar, B Dobutovic, S Soskic, V Mandusic, Z Zakula, M Misirkic, ... Journal of physiology and biochemistry 67, 195-204, 2011 | 44 | 2011 |
| Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early-and late-onset breast cancer V Mandusic, B Dimitrijevic, D Nikolic-Vukosavljevic, ... Cancer letters 321 (1), 73-79, 2012 | 32 | 2012 |
| Skewed X-chromosome inactivation in women affected by Alzheimer's disease V Bajic, V Mandusic, E Stefanova, A Bozovic, R Davidovic, L Zivkovic, ... Journal of Alzheimer's Disease 43 (4), 1251-1259, 2015 | 28 | 2015 |
| Methylation-specific PCR: four steps in primer design RS Davidović, AM Božović, VL Mandušić, MM Krajnović Central European journal of biology 9, 1127-1139, 2014 | 28 | 2014 |
| Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia N Petrović, V Mandušić, B Dimitrijević, J Roganović, S Lukić, L Todorović, ... Medical Oncology 31, 1-9, 2014 | 28 | 2014 |
| miR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis N Petrović, A Kolaković, A Stanković, S Lukić, A Řami, V Mandušić Cancer Biomarkers 16 (3), 385-394, 2016 | 27 | 2016 |
| Expression of estrogen receptor β wt isoform (ERβ1) and ERβΔ5 splice variant mRNAs in sporadic breast cancer V Mandušić, D Nikolić-Vukosavljević, N Tanić, K Kanjer, ... Journal of cancer research and clinical oncology 133, 571-579, 2007 | 27 | 2007 |
| Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-up M Markićević, R Džodić, M Buta, K Kanjer, V Mandušić, ... International journal of medical sciences 11 (7), 663, 2014 | 23 | 2014 |
| Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters L Todorović, B Stanojević, V Mandušić, N Petrović, V Živaljević, ... Medical Oncology 35, 1-10, 2018 | 19 | 2018 |
| p14ARF methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma R Davidović, J Sopta, V Mandušić, M Krajnović, M Stanojević, G Tulić, ... Medical Oncology 30, 1-8, 2013 | 15 | 2013 |
| Cathepsin D as an indicator of clinical outcome in early breast carcinoma during the first 3 years of follow-up M Markićević, K Kanjer, V Mandušić, M Buta, Z Nešković-Konstantinović, ... Biomarkers in medicine 7 (5), 747-758, 2013 | 11 | 2013 |
| Effect of chronic forced running on gene expression of catecholamine biosynthetic enzymes in stellate ganglia of rats. L Gavrilovic, V Mandusic, V Stojiljkovic, J Kasapovic, S Stojiljkovic, ... Journal of Biological Regulators and Homeostatic Agents 26 (3), 367-377, 2012 | 11 | 2012 |
| Erythrocytotoxicity of tiazofurin in vivo and in vitro detected by scanning probe microscopy V Vranić-Mandušić, V Subota, K Savovski, L Medić, T Dramićanin, ... Toxicology letters 146 (3), 275-284, 2004 | 11 | 2004 |
| Instability in X chromosome inactivation patterns in AMD: a new risk factor? B Vladan, SP Biljana, V Mandusic, M Zorana, L Zivkovic Medical Hypothesis, Discovery and Innovation in Ophthalmology 2 (3), 74, 2013 | 10 | 2013 |
| Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period B Balint, D Vucetic, M Todorovic-Balint, N Borovcanin, S Jovanovic-Cupic, ... Transfusion and Apheresis Science 49 (1), 103-104, 2013 | 8 | 2013 |
| Hematological toxicity associated with tiazofurin-influence on erythropoiesis V Vranić, K Savovski, N Dedović, B Dimitrijević Toxicology letters 114 (1-3), 81-90, 2000 | 8 | 2000 |
| Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer A Božović, M Markićević, B Dimitrijević, S Jovanović Ćupić, M Krajnović, ... Medical Oncology 30, 1-10, 2013 | 6 | 2013 |
| Effects of a modified CMF treatment (cyclophosphamide, methotrexate and 5-fluorouracil) on hematopoietic tissues and Yoshida sarcoma in rats K Savovski, N Pujič, V Vranič, B Dimitrijevič Acta Oncologica 33 (7), 793-798, 1994 | 4 | 1994 |
Ana KolakovicUniversity of Belgrade在 vin.bg.ac.rs 的电子邮件经过验证
